摘要
目的:观察奥扎格雷钠联合红花注射液治疗脑梗死的疗效并进行安全性分析。方法:选取我院在2014年3月-2016年2月收治的66例脑梗死患者,随机分为观察组(36例)和对照组(30例),均给予稳定血压、减轻脑水肿、控制血糖、防治并发症等治疗。对照组给予奥扎格雷钠静脉滴注,观察组联合红花注射液静脉滴注,疗程均为14d,观察神经功能缺损恢复情况及不良反应发生情况。结果:观察组患者治疗效果较为显著,治疗前后比较差异具有统计学意义(t=11.3051,P<0.01);观察组神经功能缺损恢复及总有效率均显著高于对照组,组间比较差异显著,具有统计学意义(分别t=2.6402,P<0.05;x2=5.8341,P<0.05)。所有患者均未出现严重的不良反应。结论:奥扎格雷钠联合红花注射液治疗脑梗死疗效更为显著,不良反应轻微,值得临床推广和应用。
Objective： To observe efficacy of ozagrel sodium plus the Honghua injection on cerebral infarction. Methods：66 patients were randomly divided into the observation group （36 cases） and control group （30 cases）. Both groups were given symptomatic treatment. The control group was given intravenous infusion of ozagrel sodium; the observation group took the Honghua injection more. Results： The total efficiency in the observation group was better, and the difference was statistically significant between before and after treatment （t=11.3051, P〈0.01）; the recovery of neuromechanism and total efficiency in the observation group were significantly higher than those in the control group （t=2.6402, P〈0.05; x^2= 5.8341, P〈0.05）. All patients did not suffer from serious adverse reactions. Conclusion： Ozagrel sodium plus the Honghua injection on cerebral infarction was more effective, and worthy of clinical application and promotion.
出处
《中医临床研究》
2016年第35期82-83,共2页
Clinical Journal Of Chinese Medicine
关键词
奥扎格雷钠
红花注射液
脑梗死
疗效
Ozagrel sodium
The Honghua injection
Cerebral infarction
Efficacy
